We are live on ! Find out more
CCA

Cravens & Co Advisors Portfolio holdings

AUM $154M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
+17.67%
3 Year Est. Return
+52.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$134M
AUM Growth
+$5.29M
Cap. Flow
-$4.95M
Cap. Flow %
-3.7%
Top 10 Hldgs %
67.11%
Holding
59
New
2
Increased
29
Reduced
20
Closed
4

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.19M
2
SBUX icon
Starbucks
SBUX
+$782K
3
DFSV
Dimensional US Small Cap Value ETF
DFSV
+$427K
4
ILMN icon
Illumina
ILMN
+$298K
5
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$279K

Top Sells

Rank Stock Value
1
SMBK icon
SmartFinancial
SMBK
+$4.94M
2
ABBV icon
AbbVie
ABBV
+$1.02M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$816K
4
RIO icon
Rio Tinto
RIO
+$723K
5
CVE icon
Cenovus Energy
CVE
+$276K

Sector Composition

Rank Sector Weight
1 Financials 11.03%
2 Technology 6.7%
3 Communication Services 4.56%
4 Consumer Discretionary 3.99%
5 Healthcare 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCI icon
51
Crown Castle
CCI
$32.7B
$232K 0.17%
2,257
+34
+2% +$3.44K
CGGO icon
52
Capital Group Global Growth Equity ETF
CGGO
$11.2B
$200K 0.15%
6,271
-806
-11% -$23.8K
VALE icon
53
Vale
VALE
$62.9B
$199K 0.15%
20,530
+376
+2% +$3.54K
PSEC icon
54
Prospect Capital
PSEC
$1.06B
$63.6K 0.05%
20,000
– –
MSOS icon
55
AdvisorShares Pure US Cannabis ETF
MSOS
$864M
$40.9K 0.03%
16,968
+1,780
+12% +$4.38K
ABBV icon
56
AbbVie
ABBV
$458B
– –
-4,866
Closed -$1.02M
CVE icon
57
Cenovus Energy
CVE
$54.6B
– –
-19,808
Closed -$276K
REGN icon
58
Regeneron Pharmaceuticals
REGN
$68.8B
– –
-1,286
Closed -$816K
RIO icon
59
Rio Tinto
RIO
$148B
– –
-12,040
Closed -$723K
1 2
3

Similar funds

CPCP
Cedar Point Capital Partners Cedar Rapids, Iowa $154M AUM 16.57% 1-Year Est. Return
SOWAS
Silver Oak Wealth Advisors Services Los Angeles, California $154M AUM 13.96% 1-Year Est. Return
AFC
Alpine Fox Capital Las Vegas, Nevada $154M AUM
SHU
SBI Holdings USA Santa Clara, California $154M AUM
FW
Fidato Wealth Middleburg Heights, Ohio $154M AUM 11.98% 1-Year Est. Return
FGI
Foresight Global Investors Purchase, New York $154M AUM 26.15% 1-Year Est. Return
HPM
H. Partners Management New York $154M AUM 19.94% 1-Year Est. Return
MDP
Millbank Dartmoor Portsmouth Asheville, North Carolina $154M AUM

Cravens & Co Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Cravens & Co Advisors held 59 positions worth $134M, up 4.1% from $129M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cravens & Co Advisors withdrew a net $4.95M in Q2 2025, closing 4 positions and reducing 20 holdings. Its most notable exit was AbbVie, an estimated $1.02M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 14% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Cravens & Co Advisors opened a new position in Eli Lilly worth $1.2M.

  • Cravens & Co Advisors's largest Q2 2025 buy was Eli Lilly: 1,534 shares worth $1.2M.
  • Cravens & Co Advisors added most to Starbucks in Q2 2025, an estimated $782K increase.
  • Cravens & Co Advisors's biggest Q2 2025 reduction was SmartFinancial, cutting an estimated $4.94M.
  • Cravens & Co Advisors fully exited AbbVie in Q2 2025, selling an estimated $1.02M.
  • Cravens & Co Advisors's ten largest holdings make up 67% of its $134M portfolio in Q2 2025.
  • Cravens & Co Advisors opened 2 new positions and closed 4 in Q2 2025.
  • Cravens & Co Advisors's portfolio value rose 4.1% quarter-over-quarter to $134M.

Based on Cravens & Co Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.